PRICE T ROWE ASSOCIATES INC /MD/
Position in BCYC — Bicycle Therapeutics PLC
CIK 80255
BALTIMORE, MD
Position in BCYC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,825,116
-$945,931 QoQ
Shares Held
902,150
-12.3% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 103 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. BCYC ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in BCYC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,825,116 | 902,150 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,771,047 | 1,028,243 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,296,251 | 1,171,787 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,718,305 | 1,384,794 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,205,331 | 1,468,393 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,045,598 | 1,536,584 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,191,778 | 1,585,127 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $38,969,765 | 1,722,040 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,161,660 | 798,501 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,000,985 | 401,646 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,005,212 | 276,837 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $11,914,434 | 593,053 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,586,713 | 297,285 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,765,476 | 318,076 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,026,496 | 338,733 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,707,328 | 417,340 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,068,759 | 421,261 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $30,096,238 | 685,876 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,453,372 | 796,014 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||